An interventional study to access the effect of Homoeopathic medicine in positive cases of COVID-19

INTERVENTION: Intervention1: Eupatorium perfoliatum 30 C: Eupatorium perfoliatum 30 C twice Daily for 5 consecutive days in empty stomach orally. One adult dose is 4 globules of no. 20 medicated globule. One child dose is 2 globules of no. 20 medicated globule. Total duration of intervention is five days. Control Intervention1: Placebo: Number 20 sugar gloubles will be used as placebo in the control arm CONDITION: Health Condition 1: B972‐ Coronavirus as the cause of diseases classified elsewhere PRIMARY OUTCOME: To assess the effectiveness of Homoeopathic medicine Eupatorium perfoliatum 30 C in preventing the progression of severity of the disease in the SARS‐Cov‐2 tested positive asymptomatic and mild cases of COVID‐19.Timepoint: 3 month SECONDARY OUTCOME: 1. To assess the changes in Quality of Life (QoL) of the subjects using WHO QOL‐BREF scale. ; 2. To assess the safety of Eupatorium perfoliatum 30 C drug by observing for adverse events.Timepoint: 3 months INCLUSION CRITERIA: 1. Subjects testing positive for SARS CoV‐2 by RT‐PCR, presenting with no symptoms or mild symptoms. 2. Subjects who are ready to provide written/digital informed consent and who are willing to participate and follow the protocol requirements of the clinical study.